Site icon pharmaceutical daily

Global Bioinformatics Market Report 2022-2026: Development of Sophisticated Bioinformatics Tools for NGS to Drive Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Bioinformatics Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.

This is all poised to grow by $ 12.95 billion during 2022-2026, accelerating at a CAGR of 17.07% during the forecast period. The market is driven by increasing R&D investments by pharmaceutical and biopharmaceutical companies, reduction in the cost of genetic sequencing, and increasing demand for protein sequencing.

This study identifies the development of sophisticated bioinformatics tools for NGS as one of the prime reasons driving the bioinformatics market growth during the next few years. Also, increasing outsourcing activities for drug discovery and rising emergence in personalized medicine will lead to sizable demand in the market.

Key Topics Covered:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/1j73fk

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version